Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01698515 · ClinicalTrials.gov registry record

Oral Health Assessment in Rheumatoid Arthritis and Other Autoimmune Diseases-- Anti- TNF Substudy

A clinical trial, sponsored by Johns Hopkins University.

Completed
Registry status
20
Enrollment target

NCT01698515: Completed study, sponsored by Johns Hopkins University.

NCT01698515 is a clinical trial that has completed, run by Johns Hopkins University. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01698515 has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
20 participants
Enrollment target

Study Summary

The objective of this study is to evaluate the effect of Tumor Necrosis Factor (TNF) inhibition on oral parameters in patients with RA and to examine changes in levels of proinflammatory cytokines in serum, gingival crevicular fluid (GCF), and saliva at an early time point (6-8 wk) and a later time point (14-16 wk) after the initiation of therapy in relation to concomitant assessment of Rheumatoid arthritis (RA) and oral clinical variables. The purposes of the study are to: 1. Determine if oral periodontal parameters are affected by TNF inhibition; 2. Examine relationships between periodontal variables and RA variables with TNF inhibition; 3. Determine if there may be potential early response markers of clinical RA response seen using ultrasensitive analysis of oral or serum cytokines.

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2012-08
Est. Completion 2016-06

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT01698515

The ClinicalTrials.gov registry entry for NCT01698515 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01698515 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01698515 about?

NCT01698515 is a clinical study titled "Oral Health Assessment in Rheumatoid Arthritis and Other Autoimmune Diseases-- Anti- TNF Substudy". The objective of this study is to evaluate the effect of Tumor Necrosis Factor (TNF) inhibition on oral parameters in patients with RA and to examine changes in levels of proinflammatory cytokines in serum, gingival crevicular fluid (GCF), and saliva at an early time point (6-8 wk) and a later time ...

What is the current status of trial NCT01698515?

This trial is currently completed. The enrollment target is 20 participants. The study started on 2012-08. Estimated completion is 2016-06.

Who is sponsoring clinical trial NCT01698515?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.